Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 281.29B, Merck(MRK) trades at $114.30. The stock has a price-to-earnings ratio of 32.49 and currently yields dividends of 2.88%.
As of 2026-06-19, Merck(MRK) stock has fluctuated between $111.57 and $115.69. The current price stands at $114.30, placing the stock +2.4% above today's low and -1.2% off the high.
The Merck(MRK)'s current trading volume is 29.52M, compared to an average daily volume of 13.84M.
In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $76.66.
In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $76.66.
MRK News
...
The decision makes Capvaxive the only pneumococcal conjugate vaccine specifically studied and indicated in the U.S. for this patient group. Phase 3 STRIDE-13 d...
Merck (MRK) announced that the U.S. FDA has approved an expanded indication for Capvaxive to include children and adolescents aged 2 through 17 years who have c...
Analyst ratings
70%
of 30 ratingsMore MRK News
With inflation, interest rate paths and growth signals pulling markets in different directions, many investors are looking for solid ground. That is where high...
A study of analyst recommendations at the major brokerages shows that Merck & Co Inc (Symbol: MRK) is the #7 broker pick, on average, out of the 30 stocks makin...
Earlier this week, Merck reported that the FDA approved KEYTRUDA and KEYTRUDA QLEX, each in combination with WELIREG, as adjuvant therapy for adults with clear...
Merck (MRK) announced the U.S. Food and Drug Administration approved KEYTRUDA and KEYTRUDA QLEX, Merck’s anti-PD-1 therapies, each in combination with WELIREG,...
The U.S. Food and Drug Administration on Friday approved a label expansion for Merck’s (MRK) oral HIF-2α inhibitor belzutifan (Welireg) in combination with its...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.